1
|
Talvitie T, Helminen M, Karsila S, Varho R, Signorelli L, Pirttiniemi P, Peltomäki T. The impact of force magnitude on the first and second maxillary molars in cervical headgear therapy. Eur J Orthod 2021; 43:648-657. [PMID: 33822027 PMCID: PMC10084717 DOI: 10.1093/ejo/cjab010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
AIM To study the effect of force magnitude on the maxillary first and second molars in cervical headgear (CHG) therapy. MATERIAL AND METHODS In this controlled clinical trial, patients (n = 40) were treated with CHG with a light (L, 300 g, n = 22) or a heavy force (H, 500 g, n = 18) magnitude. The subjects were asked to wear CHG for 10 hours a day for 10 months. The outer bow of the CHG facebow was lifted up for 10-20 degrees and the inner bow was expanded 3-4 mm. Adherence to instructions and force magnitude were monitored using an electronic module (Smartgear, Swissorthodontics, Switzerland). Panoramic and lateral radiographs before (T1) and after treatment (T2) were analysed using a Romexis Cephalometric module (Planmeca, Finland) focussing on the angular, sagittal, and vertical positions of the permanent first and second molars. RESULTS According to the cephalometric analysis of the maxillary first and second molars, distal tipping occurred during T1-T2 in the H group (P = 0.010 and 0.000, respectively), and the change was greater in the H group compared to the L group (P = 0.045 and 0.019, respectively). Based on the panoramic analysis, tipping occurred in the distal direction during therapy in the H group in the second molars compared to the midline or condylar line (P = 0.001 and 0.001; P = 0.008 and 0.003 on the right and left, respectively). CONCLUSION With heavy force magnitude, the maxillary first and second molars can tilt more easily in the distal direction even if the CHG was used less. Distal tipping of the molar can be considered to be a side effect of CHG therapy.
Collapse
Affiliation(s)
- Tuula Talvitie
- Oral Diseases, The Hospital District of South Ostrobothnia, Seinäjoki, Finland.,Institute of Dentistry, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland
| | - Mika Helminen
- Tays Research Services, Tampere University Hospital, Tampere, Finland.,Faculty of Social Sciences, Health Sciences, Tampere University, Tampere, Finland
| | - Susanna Karsila
- Dental Teaching Unit, Turku Municipal Health Care Services, Turku, Finland
| | - Reeta Varho
- Dental Teaching Unit, Turku Municipal Health Care Services, Turku, Finland
| | | | - Pertti Pirttiniemi
- Department of Oral Development and Orthodontics, Research Unit of Oral Health Sciences, University of Oulu, Finland and Medical Research Center, Oulu University Hospital, Oulu, Finland
| | - Timo Peltomäki
- Institute of Dentistry, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.,Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.,Department of Oral and Maxillofacial Diseases, Kuopio University Hospital, Kuopio, Finland.,Department of Ear and Oral Diseases, Tampere University Hospital, Tampere, Finland
| |
Collapse
|